DRI Healthcare Trust (TSE:DHT.UN) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of DRI Healthcare Trust (TSE:DHT.UNGet Free Report) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is C$21.50.

A number of research analysts recently weighed in on DHT.UN shares. CIBC increased their price objective on shares of DRI Healthcare Trust from C$19.50 to C$20.00 and gave the company an “outperform” rating in a research report on Wednesday, May 8th. Canaccord Genuity Group decreased their target price on shares of DRI Healthcare Trust from C$19.50 to C$19.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Raymond James upgraded DRI Healthcare Trust from an “outperform” rating to a “strong-buy” rating and increased their target price for the stock from C$22.00 to C$24.00 in a research report on Friday, March 1st. Stifel Nicolaus increased their price objective on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company a “buy” rating in a report on Friday, March 1st. Finally, National Bankshares raised their target price on shares of DRI Healthcare Trust from C$22.00 to C$23.50 and gave the company an “outperform” rating in a report on Friday, March 1st.

Read Our Latest Stock Analysis on DRI Healthcare Trust

DRI Healthcare Trust Trading Up 35.0 %

DRI Healthcare Trust stock opened at C$15.26 on Thursday. The stock has a 50 day moving average of C$15.84. DRI Healthcare Trust has a twelve month low of C$9.70 and a twelve month high of C$17.43.

About DRI Healthcare Trust

(Get Free Report

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Read More

Analyst Recommendations for DRI Healthcare Trust (TSE:DHT.UN)

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.